EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC/SIO survey

Alexandre Chan, Dalia Kagramanov, Reem Nasr, Chioma Asuzu, Ting Bao, Yin Ting Cheung, Jung Hye Kwon, Judith Lacey, Richard T Lee, Maryam Lustberg, Beatrice M Ohaeri, Santosh Rao und 3 weitere

Supportive Care in Cancer · 2026-08 · 34 (8)

DOI: 10.1007/s00520-026-11020-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 22.07.2026. Verfasst von Alexandre Chan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy Practice, University of California Irvine, 802 W Peltason Drive, Irvine, CA, 92697-4625, USA. a.chan@uci.edu. Hauptthemen laut MEDLINE: Integrative Oncology, Neoplasms, Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Integrative oncology (IO) modalities aim to improve the quality of life of persons with cancer, including strategies to manage treatment and disease-related symptoms. As evidence increases to include IO in supportive care, interest grows globally. Understanding barriers to IO recommendation is key to facilitating its uptake.

Methods

Members of the Multinational Association of Supportive Care in Cancer (MASCC) and the Society for Integrative Oncology (SIO) were invited to complete an online survey in Fall 2023 assessing barriers to IO recommendation on a 5-point scale. Descriptive statistics assessed demographic data and general counts of scaled agreement, while logistic regression analysis evaluated perceived barriers in relation to relevant covariates.

Results

Over 80% of respondents believed that healthcare professionals’ (HCP) lack of knowledge with IO and lack of insurance/out-of-pocket costs were barriers to recommending IO. Approximately 80% agreed that lack of referral pathways was a logistical barrier and 85% reported lack of confidence in IO as an individual-level barrier. Respondents from Europe were 2.2 times more likely to agree with the perceived barrier of HCP knowledge, compared to respondents from North America (OR 2.22, 95% CI 1.05–4.67, p = 0.036). Lastly, compared to general physicians, integrative professionals were more likely to report perceptions that IO would delay conventional care delivery (OR 3.62, 95% CI 1.56–8.43, p = 0.0003).

Conclusions

Results of this study highlight important barriers and facilitators of IO integration into standard supportive care globally. These findings represent perspectives from an international sample of MASCC and SIO members and may not apply to all oncology professionals. Further research is necessary to understand the global roadblocks that exist among practitioners interested in IO use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrative OncologyNeoplasmsHealth PersonnelHumansSurveys and QuestionnairesFemaleMaleMiddle AgedQuality of LifeAdultAttitude of Health PersonnelReferral and ConsultationHealth Knowledge, Attitudes, Practice

Stichwörter der Autor:innen

CancerCancer supportive careIntegrative oncologyInternational perspectivesOncology

Autor:innen und Institutionen

  • Department of Clinical Pharmacy Practice, University of California Irvine, 802 W Peltason Drive, Irvine, CA, 92697-4625, USA. a.chan@uci.edu.
  • Department of Clinical Pharmacy Practice, University of California Irvine, 802 W Peltason Drive, Irvine, CA, 92697-4625, USA.
  • Department of Guidance and Counselling, University of Ibadan, Ibadan, Nigeria.
  • Zakim Center for Integrative Therapies and Healthy Living, Dana-Farber Cancer Institute, Boston, MA, USA.
  • School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Division of Hemato-Oncology, Department of Internal Medicine, Chung-Ang University, Gwangmyeong Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.

Zitieren

APA

Chan, A., Kagramanov, D., Nasr, R., Asuzu, C., Bao, T., Cheung, Y. T., Kwon, J. H., Lacey, J., Lee, R. T., Lustberg, M., Ohaeri, B. M., Rao, S., Soto-Perez-de-Celis, E., Witt, C. M., & Lopez, A. M. (2026). Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC/SIO survey. Supportive Care in Cancer, 34(8). https://doi.org/10.1007/s00520-026-11020-2

Vancouver

Chan A, Kagramanov D, Nasr R, Asuzu C, Bao T, Cheung YT, et al. Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC/SIO survey. Supportive Care in Cancer. 2026;34(8). doi:10.1007/s00520-026-11020-2

BibTeX
@article{Chan2026,
  author = {Chan, Alexandre and Kagramanov, Dalia and Nasr, Reem and Asuzu, Chioma and Bao, Ting and Cheung, Yin Ting and Kwon, Jung Hye and Lacey, Judith and Lee, Richard T and Lustberg, Maryam and Ohaeri, Beatrice M and Rao, Santosh and Soto-Perez-de-Celis, Enrique and Witt, Claudia M and Lopez, Ana Maria},
  title = {Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC/SIO survey},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {8},
  doi = {10.1007/s00520-026-11020-2}
}
Kostenlos starten →